ReviewAnnals of biomedical engineering2026
Subdermal Insertable Sensors for Health Monitoring: Applications, Challenges, and Emerging Technologies.
Review in Annals of biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Continuous monitoring of chronic diseases with mobile health tools is rapidly advancing to improve patient care. Wearable sensors placed on or near the skin remain the dominant paradigm for collecting physiological data noninvasively during activities of daily living. However, wearable sensors have their limitations. Epidermal sensors are fundamentally limited by the information barrier that the skin presents. Furthermore, environmental factors impact the stability and longevity of wearables. An alternative technology is the expanding class of minimally invasive subdermal sensors, also called insertables. Key applications for subdermal sensors are reviewed, including three current clinical devices: insertable cardiac monitors, insertable continuous glucose monitors, and sub-scalp epilepsy monitors. Next, common challenges impacting performance are discussed, including device migration, device encapsulation, and misalignment with wirelessly linked wearables. Finally, recent technological advancements to mitigate these challenges are covered. With state-of-the-art approaches for achieving biocompatibility, remote powering, and wireless data transmission, the next generation of subdermal biosensors can be developed for unmet needs in chronic disease monitoring.
Indexed as
Identifiers
42530730What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.